Home  |  繁體  |  簡体
       
  Bloomage BioTechnology Corporation Limited was incorporated in Caymans Island on 3 April 2006. It holds 100% equity interest of two companies – Valuerank Holdings Limited and Farstar Enterprises Limited – which were both incorporated in the British Virgin Islands. ...more  

Interim Report

 
13-11-2017
 

Announcements and Notices - Joint Announcement - Privatisation of Bloomage Biotechnology Corporation Limited by Grand Full Development Limited by Way of A Scheme of Arrangement (under Section 86 of the Companies Law) - Results of the Option Offer

31-10-2017
 

Announcements and Notices - List of Directors and Their Role and Function

31-10-2017
 

Announcements and Notices - Joint Announcement - Proposal for the Privatisation of Bloomage Biotechnology Corporation Limited by Grand Full Development Limited by Way of A Scheme of Arrangement (under Section 86 of the Companies Law) (1) Effective Date of the Scheme and (2) Proposed withdrawal of Listing

 
HA End Products - Medical device products
The injectable hyaluronan soft tisse filling gel (Trademark: BioHyalux) is the end product the Group launched in the market in 2012. Also, we have reserved products known as the medical use sodium hyaluronate gel (Trademark: HYMOIS) and the intra-articular injection (Trademark: Hyprojoint) and so forth.
To learn more……
HA Raw Materials
The HA Materials are produced by microbial fermentation, using non-genetically modified strains from non-animal sources. The products are safe, pure and stable.
To learn more……
Links to related companies
Bloomage Freda Biopharm Co., Ltd
Beijing Bloomage Hyinc Technology Co., Ltd